Glenmark Pharma and SaNOtize announce results of its phase-III clinical trials on SaNOtize’s Nitric Oxide nasal spray Read more
FDA grants priority review to Roche’s Lunsumio for Relapsed or Refractory Follicular Lymphoma Read more